OHI · Omega Healthcare Investors Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.19B | $1.05B | $949.74M | $878.24M | $1.06B | $892.38M |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $104.14M | $88.00M | $81.50M | $69.40M | $64.63M | $59.89M |
| Total Operating Expenses | $688.02M | $648.89M | $793.58M | $799.67M | $776.99M | $734.95M |
| D&A | $325.25M | $304.65M | $319.68M | $332.41M | $342.01M | $329.92M |
| Operating Income | $624.43M | $420.75M | $255.63M | $436.14M | $416.08M | $162.33M |
| Interest Expense | $215.03M | $221.72M | $235.53M | $233.24M | $234.60M | $223.39M |
| Income Tax | $14.75M | $10.86M | $6.25M | $4.56M | $3.84M | $4.92M |
| Net Income | $406.33M | $406.33M | $242.18M | $438.8K | $428.3K | $159.33M |
| EPS - Basic | $1.96 | $1.57 | $1.01 | $1.81 | $1.76 | $0.70 |
| EPS - Diluted | $1.94 | $1.55 | $1.00 | $1.80 | $1.75 | $0.70 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $27.02M | $518.34M | $442.81M | $297.10M | $20.53M | $163.53M |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - |
| Total Assets | $10.05B | $9.90B | $9.12B | $9.41B | $9.64B | $9.50B |
| Current Liabilities | - | - | - | - | - | - |
| Long-term Debt | $4.26B | $4.84B | $5.07B | $5.29B | $5.25B | $5.17B |
| Total Liabilities | $4.61B | $5.17B | $5.36B | $5.60B | $5.53B | $5.46B |
| Stockholders' Equity | $5.18B | $4.54B | $3.57B | $3.61B | $3.91B | $3.84B |
| Retained Earnings | $4.68B | $4.09B | $3.68B | $3.44B | $3.01B | $2.59B |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $878.55M | $749.43M | $617.74M | $625.73M | $722.14M | $708.26M |
| Investing Cash Flow | ($539.79M) | ($671.16M) | ($770.0K) | $442.85M | ($524.17M) | ($89.06M) |
| Financing Cash Flow | ($838.26M) | $26.32M | ($473.31M) | ($789.45M) | ($341.12M) | ($485.55M) |
| CapEx | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | - | - |
| Operating margin | 52.5% | 40.0% | 26.9% | 49.7% | 39.1% | 18.2% |
| EBITDA margin | 79.8% | 69.0% | 60.6% | 87.5% | 71.3% | 55.2% |
| Net margin | 34.1% | 38.6% | 25.5% | 0.0% | 0.0% | 17.9% |
| Free cash flow margin | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 8.8% | 8.4% | 8.6% | 7.9% | 6.1% | 6.7% |
| Effective tax rate | 3.5% | 2.6% | 2.5% | 91.2% | 90.0% | 3.0% |
| Return on assets | 4.0% | 4.1% | 2.7% | 0.0% | 0.0% | 1.7% |
| Return on equity | 7.8% | 9.0% | 6.8% | 0.0% | 0.0% | 4.1% |
| Return on invested capital | 6.4% | 4.4% | 2.9% | 2.5% | 2.3% | 1.7% |
| Liquidity | ||||||
| Current ratio | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - |
| Leverage | ||||||
| Debt / Equity | 0.82 | 1.07 | 1.42 | 1.46 | 1.34 | 1.35 |
| Debt / Assets | 0.42 | 0.49 | 0.56 | 0.56 | 0.55 | 0.54 |
| Debt / EBITDA | 4.48 | 6.67 | 8.81 | 6.88 | 6.93 | 10.50 |
| Interest coverage | 2.9x | 1.9x | 1.1x | 1.9x | 1.8x | 0.7x |
| Equity multiplier | 1.94 | 2.18 | 2.55 | 2.61 | 2.47 | 2.47 |
| Liabilities / Assets | 0.46 | 0.52 | 0.59 | 0.60 | 0.57 | 0.57 |
| Efficiency | ||||||
| Asset turnover | 0.12 | 0.11 | 0.10 | 0.09 | 0.11 | 0.09 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | 22.9x | 24.4x | 30.7x | 15.5x | 16.9x | 51.9x |
| P / B | 2.6x | 2.3x | 2.1x | 1.9x | 1.9x | 2.2x |
| P / S | 11.4x | 9.7x | 8.1x | 7.8x | 6.8x | 9.6x |
| EV / EBITDA | 18.7x | 20.1x | 21.4x | 15.4x | 16.4x | 27.5x |
| Growth | ||||||
| Revenue growth (YoY) | 13.2% | 10.7% | 8.1% | -17.4% | 19.1% | -3.9% |
| Revenue CAGR (3y) | 10.7% | -0.4% | 2.1% | -1.8% | 5.7% | - |
| Revenue CAGR (5y) | 5.9% | 2.5% | 1.1% | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - |
| Operating income growth (YoY) | 48.4% | 64.6% | -41.4% | 4.8% | 156.3% | -70.6% |
| Net income growth (YoY) | 0.0% | 67.8% | 55086.3% | 2.5% | -99.7% | -53.3% |
| EPS growth (YoY) | 25.2% | 55.0% | -44.4% | 2.9% | 150.0% | -55.7% |
| EPS CAGR (3y) | 2.5% | -4.0% | 12.6% | 4.4% | 7.7% | 11.1% |
| EPS CAGR (5y) | 22.6% | -0.4% | -6.5% | 28.7% | -1.6% | -11.5% |
| FCF growth (YoY) | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | 14.2% | 26.9% | -1.0% | -7.6% | 1.7% | -7.1% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Geographic
$180.10M totalGB$180.10M · 100.0%
Stability scores
Piotroski F-score
FY 2025 · 9-point quality
5/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- -Current ratio improved
- ✗No share dilution
- -Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Real Estate Investment Trusts
Comparing OMEGA HEALTHCARE INVESTORS INC against the 5 most active filers in the same SIC group.
Dividends
$2.68/share trailing 12 months · 0.0% YoY
| Ex-date | Per share |
|---|---|
| May 4, 2026 | $0.6700 |
| Feb 9, 2026 | $0.6700 |
| Nov 3, 2025 | $0.6700 |
| Aug 4, 2025 | $0.6700 |
| May 5, 2025 | $0.6700 |
| Feb 10, 2025 | $0.6700 |
| Nov 4, 2024 | $0.6700 |
| Aug 5, 2024 | $0.6700 |
| Apr 29, 2024 | $0.6700 |
| Feb 2, 2024 | $0.6700 |
| Oct 30, 2023 | $0.6700 |
| Jul 28, 2023 | $0.6700 |
| Apr 28, 2023 | $0.6700 |
| Feb 3, 2023 | $0.6700 |
| Oct 31, 2022 | $0.6700 |
| Jul 29, 2022 | $0.6700 |
| Apr 29, 2022 | $0.6700 |
| Feb 4, 2022 | $0.6700 |
| Nov 4, 2021 | $0.6700 |
| Jul 30, 2021 | $0.6700 |
| Apr 30, 2021 | $0.6700 |
| Feb 5, 2021 | $0.6700 |
| Oct 30, 2020 | $0.6700 |
| Jul 30, 2020 | $0.6700 |